|
|
|
|
Sarcoma watch recommended for breast cancer patients
Cancer 2009; Advance online publication MedWire News: Women with breast cancer who receive radiotherapy or partial mastectomy should receive check-ups for at least 20 years, recommend US researchers on finding these patients have an...
|
|
|
Sarcoma Prognosis: Recent findings in sarcoma prognosis described by researchers from Rikshospitalet Universit
Recent findings in sarcoma prognosis described by researchers from Rikshospitalet University, Institute for Medical Informatics New investigation results, 'The prognostic value of DNA ploidy in a total population of uterine sarcomas,' are...
|
|
|
Irwin Barker: Being funny in spite of cancer
Irwin Barker and his comedian friends will present an evening of cancer-fighting comedy Saturday, June 13, at River Rock Show Theatre.This is Barkers second Fighting Cancer With Comedy show, which coincides with Barkers two-year...
|
|
|
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that data from the Company??s HIF-1 alpha Phase 1 study evaluating EZN-2968 in patients with solid tumors and lymphoma was presented at the...
|
|
|
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
We have yet to see a dose limiting toxicity and we continue to be encouraged by the early clinical signals in this program, said Jeffrey H.Buchalter, Enzon's Chairman and Chief Executive Officer. The duration of clinical benefit in...
|
|
|
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
- Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced that data from the Companys HIF-1 alpha Phase 1 study evaluating EZN-2968 in patients with solid tumors and lymphoma was presented at the 2009 American Society of Clinical...
|
|
|
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
BRIDGEWATER, N.J.- (BUSINESS WIRE) - Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that data from the Company's HIF-1 alpha Phase 1 study evaluating EZN-2968 in patients with solid tumors and lymphoma was presented at the...
|
|
|
What Are Fibroids? What Are The Treatments For Fibroids?
Women's Health / Gynecology News Editor's Choice Main Category: Women's Health / Gynecology email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article...
|
|
|
Oncolytics Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
CALGARY, May 12 /PRNewswire-FirstCall/ -- 'We are extremely pleased to have had the opportunity to participate in this study,' said Dr.Monica Mita, principal investigator at the Institute of Drug Development (IDD), the Cancer Therapy &...
|
